Oruka Therapeutics ORKA
$95.81 −$1.76 (-1.80%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $95.81 0.00%
Open$95.86
Prev close$97.57
Day range$93.30 – $97.24
Volume1.98M
Market cap$6.50B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts11
Average target$148.44+54.9% vs. price
- Buy 100%
Low $105.00Now $95.81Avg $148.44High $180.00
Recent rating changes
The last 20 actions on file set price targets from $105.00 to $180.00, averaging $148.68.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 10 Nov 2026 | UBS | BUY | $130.00 |
| 10 Nov 2026 | Piper Sandler | BUY | $180.00 |
| 10 Nov 2026 | Stifel | BUY | $150.00 |
| 10 Nov 2026 | H.C. Wainwright | BUY | $120.00 |
| 10 Nov 2026 | Barclays | BUY | $160.00 |
| 9 Nov 2026 | BTIG | BUY | $151.00 |
| 27 Oct 2026 | Wedbush | BUY | $165.00 |
| 27 Oct 2026 | Leerink Partners | BUY | – |
| 27 Oct 2026 | H.C. Wainwright | BUY | $120.00 |
| 27 Oct 2026 | Barclays | BUY | $160.00 |
| 26 Oct 2026 | BTIG | BUY | $151.00 |
| 26 Oct 2026 | Clear Street | BUY | $105.00 |
| 18 Oct 2026 | BTIG | BUY | $151.00 |
| 7 Oct 2026 | Piper Sandler | BUY | $180.00 |
| 1 Oct 2026 | BTIG | BUY | $151.00 |
| 24 Sep 2026 | Wedbush | BUY | $165.00 |
| 24 Sep 2026 | H.C. Wainwright | BUY | $120.00 |
| 23 Sep 2026 | LifeSci Capital | BUY | $175.00 |
| 23 Sep 2026 | Clear Street | BUY | $131.00 |
| 21 Sep 2026 | Barclays | BUY | $160.00 |
No comments yet — be the first to weigh in on ORKA.
Sign in to join the discussion.